219529-78-9 Usage
Molecular Structure
2-(4-Methoxyphenyl)-5-methyl-1,3-dioxane-5-carboxylic acid consists of a dioxane ring, a carboxylic acid group, a methyl group, and a methoxyphenyl group.
Dioxane Ring
The compound has a five-membered dioxane ring, which provides a stable and rigid structure to the molecule.
Carboxylic Acid Group
The presence of a carboxylic acid group (-COOH) makes the compound an acid and allows for the formation of hydrogen bonds, which can be important in biological activity and interactions with other molecules.
Methoxyphenyl Group
A methoxy group (-OCH3) is attached to the phenyl ring, which can affect the compound's solubility, stability, and potential biological activity.
Pharmaceutical Applications
Due to its unique structure and potential biological activities, 2-(4-Methoxyphenyl)-5-methyl-1,3-dioxane-5-carboxylic acid has potential applications in pharmaceuticals and drug development.
Medicinal Properties
The compound may possess medicinal properties, making it a candidate for use in the synthesis of new drugs or as a starting material for the development of new chemical entities.
Building Block for Synthesis
The carboxylic acid group in the compound makes it a potential building block for the synthesis of other organic compounds, expanding its utility in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 219529-78-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,5,2 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 219529-78:
(8*2)+(7*1)+(6*9)+(5*5)+(4*2)+(3*9)+(2*7)+(1*8)=159
159 % 10 = 9
So 219529-78-9 is a valid CAS Registry Number.
219529-78-9Relevant articles and documents
PROCESS FOR THE PREPARATION OF TEMSIROLIMUS AND ITS INTERMEDIATES
-
, (2011/08/06)
Novel intermediates, process for their preparation and their use in the preparation of therapeutically effective antineoplastic agents, in particular Temsirolimus of formula (I).
AN IMPROVED PROCESS FOR THE PREPARATION OF TEMSIROLIMUS AND ITS INTERMEDIATES
-
, (2011/08/21)
Novel intermediates, process for their preparation and their use in the preparation of therapeutically effective antineoplastic agents, in particular Temsirolimus of formula (I).